ArticleNature communications2026
Scalable Ni‑driven synthesis of Pt single‑site catalysts for hydrogen evolution.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pre-catalysts for the hydrogen evolution reaction: from dynamic reconstruction to rational design.Chemical science · 2026Review
- Low-Loading Pt Nanoparticles Anchored on Niobium Nitride for Highly Efficient Alkaline Hydrogen Evolution.Nanomaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Low-platinum-loading electrocatalysts, offering both high activity and durability under practical conditions, are essential for sustainable hydrogen production. Here we report a scalable synthesis of a platinum single-site catalyst supported on Ni-N-doped carbon nanotubes, achieved via a facile Ni-driven one-step reduction-displacement of Pt
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.